Magneto-plasmonic Nanoparticle Platform for Capture, Separation and Enumeration of Rare Cells

Video   May 27, 2014

 

Abstract

Detection of disseminated tumor cells or tumor biomarkers in human fluids such as blood, urine, and saliva can provide an accessible tool for cancer detection and therapy monitoring. In particular, accurate quantitation of cancer cells in the bloodstream can help to determine prognosis and monitor the effectiveness of cancer therapy. However, the challenge of detecting circulating tumor cells (CTCs) is their rare occurrence, estimated as one to few CTCs among millions of leukocytes and billions of erythrocytes. Here we address this challenging problem by developing nanoparticle probes with multiple functionalities.

 
 
 
 

Recommended Videos

Pill for Better Diagnosis of Breast Cancer

Video

Researchers from the University of Michigan have developed a diagnostic imaging pill enabling the early and more accurate diagnosis of cancerous tumors in breast tissue.

WATCH NOW

What is Nanotechnology and What's It's Role in the Food Industry?

Video

In the food area, researchers are working with nanotechnology to create novel products that may be of benefit to health and diets. What are their possible applications? Is it safe?

WATCH NOW

CellStreamâ„¢ Benchtop Flow Cytometer for Sensitive Cell Analysis

Video

The new CellStreamâ„¢ benchtop flow cytometer delivers unparalleled sensitivity and flexibility for cell and particle analysis.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Applied Sciences Cancer Research Drug Discovery Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy